Deciphering the Anti‐Diabetic Potential of Gymnema Sylvestre Using Integrated Computer‐Aided Drug Design and Network Pharmacology
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Amal Mayyas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Department of Pharmacy, American University of Madaba, Madaba, Jordan. Hauptthemen laut MEDLINE: Network Pharmacology, Hypoglycemic Agents, Gymnema sylvestre, Drug Design. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study explores novel therapeutic avenues for diabetes, a global health concern marked by elevated blood glucose levels. We investigated the anti‐diabetic potential of Gymnema Sylvestre 's bioactive compounds, including Gymnemic acid I, Stigmasterol, Deacylgymnemic acid, Beta‐Amyrin acetate, Longispinogenin, Gymnemic acid II, Gymnemic acid, Gymnemic acid X, Gymnemaside VI, Phytic acid and Gymnemic acid X. Employing network pharmacology, molecular docking and molecular dynamics (MD), we elucidated the potential mechanism of action. SwissTargetPrediction identified targets for bioactive constituents, while DisGeNET provided diabetes‐related targets. A GeneVenn diagram revealed 397 common potential targets for diabetes management. The protein–protein interaction network, constructed via the STRING database, underwent topological analysis in Cytoscape, identifying AKT1, SRC, TNF, PPARG and IL1B as top targets. Gene ontology analysis using FunRich identified crucial roles of screened targets in integrin family cell surface interactions and glypican pathways for diabetes management. Molecular interactions and binding affinities with the top target, AKT1, were assessed, with Gymnemic acid I displaying the least binding energy (−9.813) with H‐ and non‐H‐bond interactions. Molecular dynamics simulations provided insights into the distinct behaviours of Gymnemic acid I within the protein complex. In conclusion, our study elucidates the potential anti‐diabetic mechanism of Gymnemic acid I, underscoring the need for further in vitro, in vivo and clinical studies to validate our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, Department of Pharmacy, American University of Madaba, Madaba, Jordan.
- Pharmacological and Diagnostic Research Centre (PDRC), Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
- Department of Pharmacy, AL-Manara College for Medical Sciences, Amarah, Iraq.
- Research Laboratory for Bioactive Natural Products and Biotechnology LR24ES14, Faculty of Dental Medicine of Monastir, University of Monastir, Monastir, Tunisia.
- Department of Pharmacy, Hilla University College, Babylon, Iraq.
- Al-Nisour University College, Pharmacy Department, Baghdad, Iraq.
ORCID-Profile: Musaab Dauelbait, Mohammed Bourhia
Zitieren
APA
Mayyas, A., Al-Samydai, A., Oraibi, A. I., Debbabi, N., Hassan, S. S., Al-Hussainy, H. A., Salamatullah, A. M., Dauelbait, M., Bourhia, M., & Almaary, K. S. (2025). Deciphering the Anti‐Diabetic Potential of Gymnema Sylvestre Using Integrated Computer‐Aided Drug Design and Network Pharmacology. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70349
Vancouver
Mayyas A, Al-Samydai A, Oraibi AI, Debbabi N, Hassan SS, Al-Hussainy HA, et al. Deciphering the Anti‐Diabetic Potential of Gymnema Sylvestre Using Integrated Computer‐Aided Drug Design and Network Pharmacology. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70349
BibTeX
@article{Mayyas2025,
author = {Mayyas, Amal and Al-Samydai, Ali and Oraibi, Amjad Ibrahim and Debbabi, Nawres and Hassan, Sara S and Al-Hussainy, Hany Aqeel and Salamatullah, Ahmad Mohammad and Dauelbait, Musaab and Bourhia, Mohammed and Almaary, Khalid S},
title = {Deciphering the Anti‐Diabetic Potential of Gymnema Sylvestre Using Integrated Computer‐Aided Drug Design and Network Pharmacology},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70349}
}
EUVIMED